Fairly priced — no edge either way.

Close to fair value. Not a bargain, not a rip-off. Come back if the price moves.

Price $93.53 taken 2026-11-15 · market cap about $11B
Fair value $98 range $69 to $142 · from the FY25 annual report
Margin of safety +5%, below fair value a margin of safety · the price sits below fair value

The five checks

1 good · 3 caution · 1 warning

  • Caution
    Roughly fair
    Fair value ~$98 sits close to the $94 price — no real margin of safety either way.
  • Caution
    Price assumes a modest step-up
    Priced for ~4%/yr vs a 2.3%/yr record — a stretch, not heroic.
  • Warning
    Revenue shrinking
    Down 4.4% last year — cheap may mean broken.
  • Good
    Cash flow compounding
    Free cash flow up ~2.3%/yr — the engine is growing.
  • Caution
    Manageable net debt
    Net debt of $2B — about 2.3× annual free cash flow. Normal for a mature company.

Price against fair value

What today's price assumes

Hold the price fixed and work backwards: how fast would free cash flow have to grow for $94 to make sense?

The price needs ~4% a year
Albemarle has delivered 2.3% a year over the last three years

Price assumes a modest step-up.

Where this number comes from →

How fair value is calculated

No analyst forecasts, no black box, no AI. Six lines from the filing to the answer.

  1. Free cash flow, FY25Operating cash flow less capital spending, from the annual report$0.7B
  2. Ten years of it, growing 5% a year, each counted 9% lessThe same growth and discount for every company$5.6B
  3. Everything after year tenGrowing 2.5% a year, counted the same way+ $7.5B
  4. The business, in today's money$13.1B
  5. Subtract net debtBorrowings and finance leases less cash and securities− $1.6B
  6. Divide by the shares on file÷ 0.1177B

Fair value per share$98

If our assumptions are wrong

Fair value per share under a faster or slower decade, and a gentler or harsher discount. The corners are where the $69 to $142 range comes from.

3% growth5% growth7% growth
8% discount$100$119$142
9% discount$82$98$116
10% discount$69$82$98

The blue cell is the published method. Some cells sit above today’s price, some below.

Free cash flow, ten years

$ billions · Form 10-K

$0.5B FY16 −$0.0B FY17 −$0.1B FY18 −$0.1B FY19 −$0.1B FY20 −$0.6B FY21 $0.7B FY22 −$0.8B FY23 −$1.0B FY24 $0.7B FY25
  1. FY25 $0.7B
  2. FY24 −$1.0B
  3. FY23 −$0.8B
  4. FY22 $0.7B
  5. FY21 −$0.6B
  6. FY20 −$0.1B
  7. FY19 −$0.1B
  8. FY18 −$0.1B
  9. FY17 −$0.0B
  10. FY16 $0.5B

What the math is really telling you. Watch whether cash flow is compounding — that, more than any single year, is what a value read hangs on.

How this was built. Every figure is computed from Albemarle Corporation's SEC filings — no estimates, no AI. Two-stage DCF: 9% discount rate, 5% free-cash-flow growth for 10 years, 2.5% terminal. Free cash flow is operating cash flow less capital spending. Net cash is cash and marketable securities less borrowings, commercial paper and finance leases; operating leases are disclosed but never counted as debt. We subtract net debt from the value of the business — for Albemarle that is about $2B, or $14 per share. Fundamentals are from the FY25 annual report and change only when a new one is filed. Price of $93.53 taken 2026-11-15 (Google Finance, manual entry, 2026-11-13) — it is not live and does not move during the day.

Read Albemarle another way

TickerMath is an educational tool, not investment advice — it computes one model from SEC filings and can be wrong. How we compute this →